Psychoneurological symptoms |
Symptoms that often co-occur and have similar potential underlying causal pathways. Examples include pain, fatigue, sleep disturbance, anxiety, depressive symptoms, and cognitive dysfunction. |
Microbiome |
A community of microorganisms (bacteria, viruses, and fungi) that reside in different parts of the human body, such as the skin, gastrointestinal tract, oral cavity, and vagina. |
Microbial composition |
A description of the microorganisms that form the microbiome. Compositional components include microbial abundance and diversity metrics (alpha and beta diversity). |
Microbial abundance |
The quantity or proportion (relative abundance) of a specific microorganism that resides in the microbiome. |
Alpha diversity |
Measurement of microbial species diversity within a given sample or microbial site. |
Beta diversity |
Measurement of dissimilarity (or similarity) of species diversity between two or more samples or microbial sites. |
Metabolome |
The collection of small molecules (metabolites) and their interactions within a specific biological system or sample. |
Metabolites |
Small molecules that are substrates, intermediates, or products of metabolic reactions that regulate various physiological functions within a cell or organism. |
Untargeted metabolomics |
An analytical approach that aims to comprehensively detect and quantify metabolites within a sample due to limited prior knowledge; often used as an exploratory tool. |
Targeted metabolomics |
An analytical approach that aims to quantify specific types of metabolites within a sample based on known relevant metabolic pathways or physiological processes. |
Metabolomic pathway |
A sequence of chemical reactions that produce new molecules (synthesis) or breakdown complex molecules (degradation). |